Loading...
XNYS
DHR
Market cap162bUSD
Dec 04, Last price  
227.13USD
1D
-0.58%
1Q
13.45%
Jan 2017
191.79%
Name

Danaher Corp

Chart & Performance

D1W1MN
XNYS:DHR chart
P/E
41.74
P/S
6.82
EPS
5.44
Div Yield, %
0.36%
Shrs. gr., 5y
0.32%
Rev. gr., 5y
5.92%
Revenues
23.88b
-0.06%
7,984,704,0009,596,404,00011,025,917,00012,697,456,00011,184,938,00013,202,602,00016,090,540,00018,260,400,00019,118,000,00019,913,800,00020,563,100,00016,882,400,00018,329,700,00019,893,000,00017,911,100,00022,284,000,00029,453,000,00031,471,000,00023,890,000,00023,875,000,000
Net income
3.90b
-18.16%
897,800,0001,122,029,0001,369,904,0001,317,631,0001,151,704,0001,793,000,0002,172,264,0002,392,200,0002,695,000,0002,598,400,0003,357,400,0002,553,700,0002,492,100,0002,650,900,0003,008,200,0003,646,000,0006,433,000,0007,209,000,0004,764,000,0003,899,000,000
CFO
6.69b
-6.64%
1,203,801,0001,547,251,0001,645,775,0001,859,029,0001,800,834,0002,084,351,0002,626,267,0003,415,000,0003,585,300,0003,758,400,0003,801,800,0003,521,800,0003,477,800,0004,022,000,0003,951,600,0006,208,000,0008,358,000,0008,519,000,0007,164,000,0006,688,000,000
Dividend
Sep 27, 20240.27 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
IPO date
Dec 10, 1969
Employees
79,000
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT